Russell Investments Group Ltd. boosted its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 126.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,484 shares of the real estate investment trust's stock after purchasing an additional 60,061 shares during the quarter. Russell Investments Group Ltd.'s holdings in Medical Properties Trust were worth $648,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in MPW. Charles Schwab Investment Management Inc. lifted its holdings in shares of Medical Properties Trust by 13.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock valued at $60,424,000 after acquiring an additional 1,182,028 shares during the last quarter. Allianz Asset Management GmbH raised its position in Medical Properties Trust by 43.2% during the first quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock valued at $43,022,000 after purchasing an additional 2,152,861 shares during the period. Northern Trust Corp lifted its stake in shares of Medical Properties Trust by 60.8% in the 4th quarter. Northern Trust Corp now owns 6,309,149 shares of the real estate investment trust's stock valued at $24,921,000 after purchasing an additional 2,385,081 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Medical Properties Trust by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,676,474 shares of the real estate investment trust's stock worth $14,522,000 after purchasing an additional 150,760 shares during the period. Finally, Principal Financial Group Inc. increased its position in shares of Medical Properties Trust by 2.3% during the 1st quarter. Principal Financial Group Inc. now owns 2,979,094 shares of the real estate investment trust's stock valued at $17,964,000 after purchasing an additional 66,820 shares during the last quarter. 71.79% of the stock is owned by hedge funds and other institutional investors.
Medical Properties Trust Stock Down 0.3%
NYSE MPW traded down $0.02 on Wednesday, reaching $4.40. 3,066,449 shares of the stock traded hands, compared to its average volume of 10,323,611. Medical Properties Trust, Inc. has a 12 month low of $3.51 and a 12 month high of $6.55. The company has a market cap of $2.64 billion, a price-to-earnings ratio of -1.84 and a beta of 1.35. The company has a fifty day moving average price of $4.25 and a 200-day moving average price of $4.87. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.76 and a current ratio of 2.76.
Medical Properties Trust (NYSE:MPW - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The firm had revenue of $240.36 million during the quarter, compared to the consensus estimate of $231.90 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business's revenue was down 9.8% compared to the same quarter last year. As a group, research analysts forecast that Medical Properties Trust, Inc. will post 0.78 EPS for the current fiscal year.
Medical Properties Trust Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 9th. Investors of record on Thursday, September 11th will be issued a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 7.3%. The ex-dividend date of this dividend is Thursday, September 11th. Medical Properties Trust's dividend payout ratio (DPR) is presently -13.39%.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. Wall Street Zen downgraded Medical Properties Trust from a "hold" rating to a "sell" rating in a research report on Saturday, July 5th. Wells Fargo & Company dropped their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating for the company in a research note on Wednesday, August 27th. Zacks Research raised shares of Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 20th. Finally, Royal Bank Of Canada dropped their target price on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a research report on Monday, June 30th. Two investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $5.58.
View Our Latest Report on Medical Properties Trust
About Medical Properties Trust
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Recommended Stories

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.